Pauline Lansiaux

Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients

Lucas C. M. Arruda, Kelen Cristina Ribeiro Malmegrim, João Rodrigues Lima-Júnior et al. · Blood Advances · 2018 · 93 citations · Full text

Life Sciences, Pathobiology, Clinical Immunology +16

Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study

Dominique Farge, Séverine Loisel, Matthieu Resche‐Rigon et al. · The Lancet Rheumatology · 2022 · 37 citations · Full text

Medicine, Hematology, Immunology +12

Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis

G. Pugnet, Zora Marjanovic, C. Deligny et al. · The Journal of Rheumatology · 2018 · 28 citations

Medicine, Physical Medicine, Physical Therapy +9

Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events

Sandrine Laurance, Pauline Lansiaux, François‐Xavier Pellay et al. · Haematologica · 2011 · 27 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis

Séverine Loisel‐Meyer, Pauline Lansiaux, Delphine Rossille et al. · Stem Cells Translational Medicine · 2023 · 25 citations · Full text

Life Sciences, Clinical Sciences, Immunology +14